Skip to content

Bio-Techne TECH Long-Term Debt and Finance Lease Obligations

Long-Term Debt and Finance Lease Obligations at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Charles River Laboratories logo
Charles River LaboratoriesCRL
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's long-term debt and finance lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's long-term debt and finance lease obligations?
Bio-Techne (TECH) reported long-term debt and finance lease obligations of $200M in Q1 2026.
How has Bio-Techne's long-term debt and finance lease obligations changed year-over-year?
Bio-Techne's long-term debt and finance lease obligations decreased by 39.4% year-over-year, from $330M to $200M.
What is the long-term trend for Bio-Techne's long-term debt and finance lease obligations?
Over 4 years (2021 to 2025), Bio-Techne's long-term debt and finance lease obligations has grown at a 1.3% compound annual growth rate (CAGR), from $328.83M to $346M.